Submitted by Anonymous (not verified) on 17 October 2024 - 16:06
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 46, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 46, Status: Authorised